GGrantIndex
Sort

1,049,261 grants matching t cell

Transmembrane Signaling Mechanisms

$2,781,391
Lutz Birnbaumer · National Institute Of Environmental Health Sciences · ZIG · FY2010 · ES

Stanford Mendelian Genomics Research Center

$2,781,357
Stephen Montgomery · Stanford University · U01 · FY2025 · HG

Circuit-specific cell types in aging and Alzheimer's disease

$2,781,184
Kuo-Fen Lee · Salk Institute For Biological Studies · U01 · FY2025 · AG

NHGRI/DIR Scientific Computing

$2,781,180
Andreas Baxevanis · National Human Genome Research Institute · ZIH · FY2021 · HG

Pharmacogenetics of Anticancer Agents Research Group

$2,781,123
Mark J Ratain · University Of Chicago · U01 · FY2008 · GM

Mitochondrial Target for Radiation Mitigation

$2,780,452
Joel S Greenberger · University Of Pittsburgh At Pittsburgh · U19 · FY2010 · AI

Ubiquitin signaling for protein degradation

$2,780,315
Kylie Walters · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Optimizing the Immunogenicity of MVA-Based AIDS Vaccines

$2,780,254
Mark B. Feinberg · Emory University · U19 · FY2006 · AI

Moffitt Cancer Center Support Grant

$2,780,246
William S. Dalton · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2007 · CA

Moffitt Cancer Center Support Grant

$2,780,246
William S. Dalton · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2008 · CA

Molecular profiling and immunomodulatory interventions

$2,780,168
Abraham Na Shaked · University Of Pennsylvania · U01 · FY2007 · AI

Development of anti-LPS therapeutic antibodies for the treatment of Pseudomonas aeruginosa infections

$2,779,955
Mariette Barbier · West Virginia University · R01 · FY2025 · AI

Expression, Structure/function And Regulation Of Phosphodiesterase 3 Isoforms

$2,779,790
Vincent Manganiello · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL

Core C: Preclinical Models Core

$2,779,554
Eric Alejandro Sweet-Cordero · Dana-Farber Cancer Inst · U54 · FY2018 · CA

Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.

$2,779,530
Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL

Immune Modulation After Allogeneic HCT

$2,779,234
Robert Jon Soiffer · Dana-Farber Cancer Inst · P01 · FY2019 · CA

COORDINATION, MONITORING, FOLLOW-UP, AND EVALUATION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION

$2,779,148
Clint Dart · Health Decisions, Inc. · N01 · FY2024 · HD

Post-transcriptional control of Proliferation, Stress Response & Carcinogenesis

$2,779,058
Myriam Gorospe · National Institute On Aging · ZIA · FY2024 · AG

Alzheimer's Disease Research Center

$2,778,928
Thomas J Montine · University Of Washington · P50 · FY2012 · AG

microRNA-based and novel molecular therapeutics in thoracic cancers

$2,778,471
Chuong Hoang · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Stanford Mendelian Genomics Research Center

$2,778,468
Stephen Montgomery · Stanford University · U01 · FY2024 · HG

The role of the ribosome and translation factors in mediating stress signaling

$2,777,852
Hani Zaher · Washington University · R35 · FY2025 · GM

The Vascular Fibroblast: An Understudied Culprit In Postoperative Venous Stenosis

$2,777,206
Laisel Martinez · University Of Miami School Of Medicine · R01 · FY2025 · DK

Inter-alpha Inhibitors in Hypoxic-Ischemic Brain Injury

$2,776,920
Yow-Pin Lim · Prothera Biologics, Llc · R44 · FY2023 · NS

Hematopoietic Cell Transplantation for Hematologic Malignancies

$2,776,839
Stephen J Forma · Beckman Research Institute/City Of Hope · P01 · FY2007 · CA